Table 1.
Clinical characteristics of cases in this study (information derived from the TCGA database).
| Clinical characteristics | ESCA tumor tissue | Normal tissue | ||
|---|---|---|---|---|
| ESCC | EAD | |||
| Age (year) | 36-90 | 47-86 | 51-90 | |
| [range (mean ± SD)] | (59.45 ± 10.60) | (72.75 ± 10.75) | (73.45 ± 10.98) | |
| Gender | Male | 36 | 15 | 15 |
| Female | 4 | 5 | 7 | |
| Pathologic T-stage | T1 | 2 | 8 | – |
| T2 | 10 | 2 | – | |
| T3 | 24 | 9 | – | |
| T4 | 2 | 0 | – | |
| Not reported | 2 | 1 | – | |
| Pathologic N-stage | N0 | 27 | 6 | – |
| N1 | 11 | 8 | – | |
| N2 | 0 | 3 | – | |
| N3 | 0 | 2 | – | |
| Not reported | 2 | 1 | – | |
| Pathologic M-stage | M0 | 35 | 9 | – |
| M1 | 1 | 1 | – | |
| MX | 1 | 6 | – | |
| Not reported | 3 | 4 | – | |
| Overall stage | Stage I | 2 | 6 | – |
| Stage II | 26 | 4 | – | |
| Stage III | 9 | 6 | – | |
| Stage IV | 1 | 1 | – | |
| Not reported | 2 | 3 | – | |
| Overall survival status | Alive | 28 | 14 | – |
| Dead | 11 | 6 | – | |
| Not reported | 1 | 0 | – | |
| Overall survival time (day) | 96-1688 | 9-1458 | – | |
| [range (mean ± SD)] | (551.90 ± 435.05) | (405.28 ± 284.02) | ||
| Total number | 40 | 20 | 22 | |
ESCA, esophageal carcinoma; EAD, esophageal adenocarcinoma; ESCC, esophageal squamous cell carcinoma. SD, standard deviation.